Duloxetine Capsule, Delayed Release
Product Images NDC 50090-6893

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-6893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Duloxetine Fig1)

FDA Label Image

Figure10 (Duloxetine Fig10)

FDA Label Image

Figure2 (Duloxetine Fig2)

This text appears to be a graph showing the proportion of patients with relapse over time for two different treatments: placebo and duloxetine. The x-axis represents the time from randomization to relapse in days, ranging from 0 to 300. The y-axis represents the proportion of patients with relapse, ranging from 0% to 10%. The graph shows the data points for both treatments and suggests a comparison between the effectiveness of the placebo and duloxetine in preventing relapse.*

FDA Label Image

Figure3 (Duloxetine Fig3)

Not available*

FDA Label Image

Figure4 (Duloxetine Fig4)

FDA Label Image

Figure5 (Duloxetine Fig5)

FDA Label Image

Figure6 (Duloxetine Fig6)

FDA Label Image

Figure7 (Duloxetine Fig7)

FDA Label Image

Figure8 (Duloxetine Fig8)

FDA Label Image

Figure9 (Duloxetine Fig9)

FDA Label Image

Structure (Duloxetine Structure)

FDA Label Image

Label Image (Lbl500906893)

This is a description of a medication called BOLoXETINE. It is a delayed-release formulation that contains 60 mg of the active ingredient. The product comes in a package of 90 capsules. The recommended storage temperature is at or below 77 degrees Fahrenheit.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.